1. Home
  2. INSG vs PLRX Comparison

INSG vs PLRX Comparison

Compare INSG & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$4.33

Market Cap

59.2M

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

SELL

Current Price

$0.99

Market Cap

63.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
INSG
PLRX
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.2M
63.2M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
INSG
PLRX
Price
$4.33
$0.99
Analyst Decision
Strong Buy
Hold
Analyst Count
3
6
Target Price
★ $13.67
$2.67
AVG Volume (30 Days)
331.9K
★ 373.1K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.97
EPS
★ 0.13
N/A
Revenue
★ $313,832,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.21
N/A
P/E Ratio
$35.19
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.58
$0.97
52 Week High
$21.90
$1.95

Technical Indicators

Market Signals
Indicator
INSG
PLRX
Relative Strength Index (RSI) 47.44 34.84
Support Level $3.96 N/A
Resistance Level $4.61 $1.37
Average True Range (ATR) 0.27 0.04
MACD 0.10 -0.01
Stochastic Oscillator 57.10 11.39

Price Performance

Historical Comparison
INSG
PLRX

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: